Results 241 to 250 of about 379,595 (283)

It's not “just aging”: Reframing postmenopausal urological dysfunction in primary care

UroPrecision, EarlyView.
Maya Aldeeb, Ibrahim A. Khalil
wiley   +1 more source

Healthcare Utilization and Costs After Appropriate or Inappropriate Implantable Defibrillator Shocks: A Retrospective Real-World Data Study in Japan. [PDF]

Clinicoecon Outcomes Res
Noda T, Matsumoto T, Tanaka Y, Goto T.
europepmc   +1 more source

Cardiac Contractility Modulation and Arrhythmic Burden in Heart Failure: Mechanistic Rationale, Clinical Evidence, and Future Perspectives. [PDF]

J Cardiovasc Dev Dis
Palermi A, Saraullo S, Faustino M, Sacchetta D, Magnano R, Mazzocchetti L, Guarracini S, Di Marco M, Furia N, Gallina S, Renda G.   +10 more
europepmc   +1 more source

Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management

International Journal of Cardiology, 2015
The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the need for transvenous leads, and therefore has the potential to improve lead-longevity and reduce lead-related complications. The S-ICD has a morphology-based sensing algorithm of which inappropriate shocks have been reported.We analyzed the incidence, predictors and
Dominic Theuns
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks

Cardiac Electrophysiology Clinics, 2018
Use of implantable cardioverter-defibrillators as a primary prevention therapy has been shown to reduce mortality in patients after cardiac arrest and also with left ventricular systolic dysfunction. Yet, inappropriate shocks are variably reported and associated with a reduction in quality of life.
Nitin Kulkarni
exaly   +3 more sources

Pre-implant predictors of inappropriate shocks with the third-generation subcutaneous implantable cardioverter defibrillator.

Europace, 2022
International audienceAbstract Aims Despite recent improvements, inappropriate shocks emitted by implanted subcutaneous implantable cardioverter defibrillators (S-ICDs) remain a challenge in ‘real-life’ practice. We aimed to study the pre-implant factors
Nicolas Badenco, Pierre Ollitrault
exaly   +2 more sources

Fatal Inappropriate ICD Shock

Journal of Cardiovascular Electrophysiology, 2006
Introduction: Inappropriate implantable cardioverter defibrillator (ICD) therapy carries a low but relevant risk of ventricular proarrhythmia. In the present case, the extremely rare event of a fatal arrhythmia caused by inappropriate therapy is reported.
Christian, Veltmann, Martin, Borggrefe, Rainer, Schimpf, Christina, Wolpert   +3 more
openaire   +2 more sources